| Name | (R)-Monlunabant |
|---|---|
| Synonyms | Acetamide, N-[[[[(4R)-3-(4-chlorophenyl)-4,5-dihydro-4-phenyl-1H-pyrazol-1-yl][[[4-(trifluoromethyl)phenyl]sulfonyl]amino]methylene]amino]iminomethyl] |
| Description | (R)-Monlunabant ((R)-MRI-1891) is a CB1 receptor mediators for research of obesity and metabolic disease[1] |
|---|---|
| Related Catalog | |
| References |
[1]. George Kunos, et al. Cannabinoid receptor mediating compounds. Patent. US20180273485. |
| Molecular Formula | C26H22ClF3N6O3S |
|---|---|
| Molecular Weight | 591.00 |